The results in GEPIA database showed that the expression of NCAPH was significantly higher in esophageal carcinoma, breast invasive adenocarcinoma, head and neck squamous cell carcinoma, and bladder urothelial carcinoma than that in normal tissues (Fig. 1E). This evidence concerns the gene NCAPH and head and neck squamous cell carcinoma.